Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Tag: EPITOPE
DBV Outlines Path to Regulatory Approval of Viaskin Peanut Patch
Dave Bloom
-
2023/04/21
Are Viaskin therapies finally on the horizon?
Skin Patch Immunotherapy Determined Safe and Effective in Toddlers With Peanut...
Dave Bloom
-
2022/11/17
According to research presented at this year's #ACAAI22 meeting.
DBV Announces Positive Topline Results from Phase 3 Trial of Viaskin...
News Wire ~ 3rd Party Press Release
-
2022/06/08
Viaskin Peanut demonstrated a statistically significant treatment effect with 67.0% of subjects meeting the treatment responder criteria after 12 months.
Will the Viaskin “Patch” Therapy for Peanut Allergy be Approved Soon?...
Dave Bloom
-
2020/06/30
Company is restructuring in anticipation of delays.
Viaskin Peanut Completes Phase III Part A Study of Toddlers With...
News Wire ~ 3rd Party Press Release
-
2018/09/12
Part B expected to commence in 2018Q4 with Viaskin Peanut 250 µg.